Vimarsana
Biggest News Aggregation in the World

Escape Bio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Escape Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Escape Bio Today - Breaking & Trending Today

Coupa Software Reports First Quarter Fiscal 2023 Financial Results - Vimarsana News

Coupa Software Reports First Quarter Fiscal 2023 Financial Results

/PRNewswire/ -- Coupa Software (NASDAQ: COUP) today announced financial results for its first fiscal quarter ended April 30, 2022....

UC Davis, UC CoM Identify Key Regulatory Mechanism in Inflammation - Vimarsana News

UC Davis, UC CoM Identify Key Regulatory Mechanism in Inflammation

UC News about Entomology and Nematology.

Source: ucanr.edu
Another $80M: mRNA biotech ReCode matches 2020 series A with Pfizer, Sanofi money for cystic fibrosis trial - Vimarsana News

Another $80M: mRNA biotech ReCode matches 2020 series A with Pfizer, Sanofi money for cystic fibrosis trial

ReCode Therapeutics is back with its second $80 million financing round, this time a series B from Pfizer, Sanofi and VC shops, to bring its lead programs into human trials. Up first are cystic fibrosis and primary ciliary dyskinesia, another lung disease.

Chutes & Ladders—FDA's vaccine office gets new leader as 2 officials head toward exit - Vimarsana News

Chutes & Ladders—FDA's vaccine office gets new leader as 2 officials head toward exit

FDA's vaccines office is now headed by Peter Marks after the agency's top two vaccine officials questioned the need for booster doses last month as they head toward the exit later this fall. Houston biotech incubator Sporos Biosciences snagged ex-Ovid Therapeutics Chief Medical Officer Amit Rakhit as its new CEO. In spinning off its gene therapy unit, Amicus' CEO will head to the new company being launched via a SPAC.